No image available
Nigerian sickle-cell drug mired in controversy
A Nigerian initiative to produce large quantities of a new drug against sickle-cell anaemia is mired in accusations of fraud and corruption.
Xechem International
You are viewing the M&G archive site.
Go to mg.co.za →
The Mail & Guardian has a new home.
Visit the new mg.co.za →